The European Patent Office (EPO) has published patent application EP4622971A1, detailing pyridine derivatives identified as potential protein kinase inhibitors. The application, filed by Hirundo Biosciences, includes specific chemical structures and classifications (IPC C07D 401/14, A61P 35/00, A61K 31/4439) and lists designated states across Europe where patent protection is sought.

This publication represents a new patent filing and does not impose immediate compliance obligations. However, it is relevant for pharmaceutical and drug development companies operating in or seeking to patent in the designated European states. Companies involved in kinase inhibitor research or protein kinase inhibitor development should be aware of this publication as it may impact their intellectual property landscape and competitive analysis.